Navigating the procurement process for high-purity recombinant proteins requires rigorous verification of analytical data, structural authenticity, and lot-to-lot consistency. PX1 Research provides certified research-grade Follistatin synthesized under strict quality controls for qualified laboratory investigators. Every batch undergoes comprehensive HPLC, mass spectrometry, and endotoxin testing to ensure reproducible experimental outcomes.
Navigating the procurement process for high-purity recombinant proteins requires rigorous verification of analytical data, structural authenticity, and lot-to-lot consistency. PX1 Research provides certified research-grade Follistatin synthesized under strict quality controls for qualified laboratory investigators. Every batch undergoes comprehensive HPLC, mass spectrometry, and endotoxin testing to ensure reproducible experimental outcomes.
When looking to bestellen follistatin peptide online for laboratory research, qualified investigators must source the material from analytical-grade chemical suppliers providing verified lot-specific documentation. Premium research-grade Follistatin is manufactured under controlled standards in the USA, requiring rigorous purity testing via Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) and Electrospray Ionization Mass Spectrometry (ESI-MS) to ensure precise structural identity and freedom from endotoxin contamination before experimental deployment.
Investigators acquiring reagents online must prioritize vendors offering full transparency, including accessible Certificate of Analysis (COA) records per lot. Purchasing unverified proteins risks experimental invalidation due to truncated sequences, isoform misfolding, or bio-burden contamination. Sourcing through validated suppliers such as PX1 Research guarantees that each vial contains authenticated sequence content engineered specifically for in vitro assays and preclinical animal models.
Follistatin (FST) is an autocrine, cysteine-rich glycoprotein expressed across diverse tissue types, functioning primarily as an endogenous antagonist to select members of the Transforming Growth Factor-beta (TGF-β) superfamily. Structurally, the core protein comprises an N-terminal domain followed by three conserved Follistatin domains (FS1, FS2, and FS3), each containing specific disulfide bond arrangements essential for high-affinity ligand binding.
Alternative splicing of the FST transcript yields distinct isoforms with differing domain architectures and tissue binding affinities. The primary recombinant variant examined in laboratory models is Follistatin-344, a precursor peptide that undergoes C-terminal processing to form the circulating Follistatin-315 isoform, or terminal cleavage to yield the tissue-bound Follistatin-288 variant. The presence of a heparin-binding sequence within the FS2 domain determines whether the specific isoform adheres to cell-surface proteoglycans or circulates freely in systemic culture media.
Understanding these structural nuances is critical when selecting reagents from our catalog of research peptides. Researchers must select the precise isoform matching their experimental framework—whether studying cell-surface receptor sequestration in localized cell cultures or systemic ligand regulation in complex physiological models.
The primary mechanism of action characterized for Follistatin centers on its ability to bi-physically sequester circulating activins and myostatin (Growth Differentiation Factor 8 / GDF-8). In vitro binding assays demonstrate that Follistatin wraps around the dimeric ligand, neutralizing its ability to engage ActRIIB (Activin Type IIB) membrane receptors. Preclinical studies suggest that this competitive inhibition prevents downstream phosphorylation of Smad2 and Smad3 transcription factors, effectively silencing the canonical signaling cascade responsible for cellular catabolism and growth suppression.
By occupying the receptor-binding epitopes of GDF-8 and Activin A, Follistatin permits uninhibited intracellular signaling through anabolic cascades, such as the Akt/mTOR network. In vitro cell culture models using C2C12 myoblasts show that treatment with recombinant Follistatin maintains protein synthesis pathways even under nutrient-deprived or catabolic stress conditions. Detailed molecular pathways are documented in our review of myostatin pathway research.
Preclinical investigation into Follistatin spans decades of cellular biology and transgenic animal research. Rodent models overexpressing Follistatin or treated with vector-mediated gene transfer exhibit significant increases in skeletal muscle cross-sectional area and marked decreases in body fat deposition without altering cardiac tissue mass. These animal studies suggest that myostatin blockade operates via distinct tissue-selective mechanisms.
In vitro data indicate that Follistatin also plays a modulating role in reproductive biology, folliculogenesis, and inflammatory cascade modulation via Activin A neutralization. In cellular models of fibrosis, Follistatin administration reduced collagen deposition by blunting TGF-β-mediated fibroblast differentiation. Such multi-systemic activity highlights the necessity of using ultra-pure, un-degraded peptide preparations when conducting quantitative ELISA, Western blotting, or receptor binding kinetics.
Quantifying the purity and structural integrity of recombinant proteins is non-negotiable for rigorous scientific inquiry. When laboratories option to bestellen follistatin peptide online, the underlying chemical grade must be verified via analytical Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC). RP-HPLC separates the target peptide from synthesis byproducts, truncated fragments, and organic impurities, displaying the primary peak as a single sharp signal with integrated peak area percentages exceeding 98.0%.
Electrospray Ionization Mass Spectrometry (ESI-MS) further confirms molecular weight to within exact Dalton tolerances. Mass spec verification eliminates ambiguity regarding amino acid sequence errors or incomplete disulfide bridging. PX1 Research enforces rigorous third-party testing protocols for every production batch through ISO 17025 accredited analytical laboratories, providing transparent spectral data accessible to every institutional partner.
Bacterial endotoxins (lipopolysaccharides / LPS) present a major hazard in cell culture and animal model experiments. High endotoxin levels trigger non-specific toll-like receptor (TLR4) activation, inducing severe inflammatory artifact responses that invalidate cytokine profiling, gene expression assays, and cell viability measurements.
PX1 Research enforces strict limits on endotoxin contamination, utilizing Chromogenic Limulus Amebocyte Lysate (LAL) testing to ensure levels remain below <0.01 EU/µg of protein. Operating out of GMP-compliant synthesis facilities, our production line minimizes biological contamination risks, establishing a baseline of high purity suited for sensitive immunological and cellular research protocols.
Researchers evaluating hypertrophy pathways often analyze Follistatin alongside other key regulators of cellular differentiation and growth. A comparative assessment of these mechanisms highlights key operational distinctions:
1. Follistatin-344 vs. Follistatin-315: While Follistatin-344 functions as a precursor encoding the full C-terminal sequence, Follistatin-315 represents the primary systemic circulating isoform, exhibiting distinct tissue distribution profiles due to variable heparin-binding affinity.
2. Follistatin vs. IGF-1 LR3: Follistatin operates via negative regulation (antagonizing inhibitory ligands like myostatin and activin), whereas IGF-1 LR3 functions as a direct positive agonist at the IGF-1 receptor, activating the PI3K/Akt path directly.
3. Follistatin vs. PEG-MGF: Mechano-Growth Factor derivatives drive localized satellite cell activation and tissue repair following mechanical damage, contrasting with Follistatin's systemic suppression of catabolic TGF-β signals.
To explore comparative data across multiple peptide classes, researchers can access the comprehensive PX1 Research repository for detailed biochemical breakdowns.
Proper reconstitution techniques are critical to preserve the tertiary structure of lyophilized recombinant proteins. Reconstitution should be performed in a certified biosafety cabinet using sterile, ultra-pure water or specialized reconstitution media such as 0.9% bacteriostatic sodium chloride or dilute acetic acid (10–50 mM) depending on the target pH range of the assay.
To solubilize lyophilized Follistatin, gently add the solvent along the inner glass wall of the vial. Allow the liquid to absorb into the cake without vigorous shaking, as mechanical shear stress can induce protein denaturation, aggregation, and loss of biological activity. Swirl gently until complete dissolution is achieved. For extended assay series, prepare single-use aliquots in low-binding microcentrifuge tubes to prevent adsorption loss.
Lyophilized Follistatin peptides maintain maximum chemical stability when stored at -20°C or -80°C in a manual defrost freezer away from light and moisture. Storage containers should contain desiccant packs to prevent humidity ingress during temperature fluctuations.
Once reconstituted into aqueous solution, Follistatin should be kept at 2°C to 8°C for short-term handling (not exceeding 7 days). For long-term storage of reconstituted stock solutions, freeze aliquots at -80°C with carrier proteins (such as 0.1% Bovine Serum Albumin or Human Serum Albumin) to prevent surface adsorption. Repeated freeze-thaw cycles must be rigorously avoided, as ice crystal formation cleaves peptide backbones and causes protein aggregation.
Procuring research compounds online requires absolute confidence in supplier supply chain security and batch consistency. PX1 Research operates state-of-the-art dispatch hubs located in California and Arizona, providing immediate order processing and same-day dispatch for orders placed Monday through Friday before cut-off times.
Every batch of Follistatin supplied by PX1 Research includes lot-tracked documentation verifying manufacturing standards, chemical composition, and analytical purity. Institutional buyers establishing high-volume assay pipelines can request custom quotes and dedicated account management through our bulk research accounts portal. Additional insights into peptide kinetics and experimental design can be reviewed in our analysis of growth factor signaling pathways.
What purity standard should I expect when I bestellen follistatin peptide online?
Analytical-grade Follistatin for laboratory research should demonstrate an HPLC purity of ≥98.0% alongside ESI-MS mass verification confirming exact sequence weight. PX1 Research provides lot-specific COAs confirming these parameters.
How does Follistatin-344 differ structurally from Follistatin-315?
Follistatin-344 is the precursor peptide sequence containing 344 amino acids, which undergoes post-translational processing to generate the circulating Follistatin-315 variant. Differing terminal lengths alter tissue heparin-binding affinity.
What endotoxin limit is acceptable for cell culture experiments using Follistatin?
To avoid non-specific inflammatory responses and TLR4 activation in vitro, endotoxin levels should remain below <0.01 EU/µg of protein, verified via LAL assay.
What solvent is recommended for reconstituting lyophilized Follistatin?
Standard laboratory reconstitution utilizes sterile bacteriostatic water or sterile 0.9% saline. For long-term aliquot storage, adding a 0.1% BSA or HSA carrier protein reduces microcentrifuge tube adsorption.
Why is vigorous vortexing avoided during peptide reconstitution?
Vortexing creates high surface shear forces that can denature tertiary protein structures, induce hydrophobic aggregation, and decrease biological binding activity in assays.
Can reconstituted Follistatin undergo multiple freeze-thaw cycles?
No. Multiple freeze-thaw cycles cause physical stress from ice crystal formation, leading to peptide cleavage and irreversible aggregation. Aliquoting into single-use volumes is standard lab protocol.
What shipping conditions are utilized by PX1 Research to protect peptide stability?
PX1 Research packages lyophilized compounds in temperature-controlled, shock-resistant packaging dispatched from California and Arizona facilities to maintain structural stability during transit.
Are Follistatin products from PX1 Research suitable for human administration?
No. All products provided by PX1 Research are strictly designated for laboratory research use only (RUO) and in vitro / preclinical experimentation. They are never for human consumption, therapeutic, or clinical use.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.